Loading insider details...
Beta
Latest Form 4 (Sep 23, 2026): Sale of 302 OKUR shares, $898.21.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | OnKure Therapeutics, Inc. (OKUR) | Sale | 302 | $898.21 |
| Aug 11, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 50,000 | n/a |
| Jun 24, 2026 | OnKure Therapeutics, Inc. (OKUR) | Sale | 303 | $1.3K |
| Apr 3, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 110,000 | n/a |
| Mar 24, 2026 | OnKure Therapeutics, Inc. (OKUR) | Sale | 301 | $1.3K |
| Dec 24, 2025 | OnKure Therapeutics, Inc. (OKUR) | Sale | 302 | $896.25 |
| Sep 24, 2025 | OnKure Therapeutics, Inc. (OKUR) | Sale | 303 | $794.92 |
| Jun 25, 2025 | OnKure Therapeutics, Inc. (OKUR) | Sale | 303 | $722.41 |
| Apr 8, 2025 | OnKure Therapeutics, Inc. (OKUR) | Sale | 1,278 | $4.3K |
| Jan 30, 2025 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 65,000 | n/a |